<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="iso-abbrev">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="publisher-id">ECAM</journal-id><journal-title-group><journal-title>Evidence-based Complementary and Alternative Medicine : eCAM</journal-title></journal-title-group><issn pub-type="ppub">1741-427X</issn><issn pub-type="epub">1741-4288</issn><publisher><publisher-name>Hindawi Publishing Corporation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24348719</article-id><article-id pub-id-type="pmc">3857908</article-id><article-id pub-id-type="doi">10.1155/2013/759615</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>
<italic>Citrus bergamia</italic> Risso Elevates Intracellular Ca<sup><bold>2+</bold></sup> in Human Vascular Endothelial Cells due to Release of Ca<sup><bold>2+</bold></sup> from Primary Intracellular Stores</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kang</surname><given-names>Purum</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Han</surname><given-names>Seung Ho</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Moon</surname><given-names>Hea Kyung</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Lee</surname><given-names>Jeong-Min</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Kim</surname><given-names>Hyo-Keun</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Min</surname><given-names>Sun Seek</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Seol</surname><given-names>Geun Hee</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor2">*</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department of Basic Nursing Science, School of Nursing, Korea University, 145 Anam-ro, Seongbuk-gu, Seoul 136-701, Republic of Korea</aff><aff id="I2"><sup>2</sup>Department of Physiology and Biophysics, School of Medicine, Eulji University, Youngdu-dong, Jung-gu, Daejeon 301-746, Republic of Korea</aff><aff id="I3"><sup>3</sup>KT&#x00026;G Research Institute, Daejeon 305-805, Republic of Korea</aff><author-notes><corresp id="cor1">*Sun Seek Min: <email>ssmin@eulji.ac.kr</email> and </corresp><corresp id="cor2">*Geun Hee Seol: <email>ghseol@korea.ac.kr</email></corresp><fn fn-type="other"><p>Academic Editor: Mohamed Eddouks</p></fn></author-notes><pub-date pub-type="ppub"><year>2013</year></pub-date><pub-date pub-type="epub"><day>21</day><month>11</month><year>2013</year></pub-date><volume>2013</volume><elocation-id>759615</elocation-id><history><date date-type="received"><day>26</day><month>6</month><year>2013</year></date><date date-type="rev-recd"><day>28</day><month>10</month><year>2013</year></date><date date-type="accepted"><day>28</day><month>10</month><year>2013</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2013 Purum Kang et al.</copyright-statement><copyright-year>2013</copyright-year><license xlink:href="https://creativecommons.org/licenses/by/3.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>The purpose of the present study is to examine the effects of essential oil of <italic>Citrus bergamia</italic> Risso (bergamot, BEO) on intracellular Ca<sup>2+</sup> in human umbilical vein endothelial cells. Fura-2 fluorescence was used to examine changes in intracellular Ca<sup>2+</sup> concentration [Ca<sup>2+</sup>]<sub>i</sub>
. In the presence of extracellular Ca<sup>2+</sup>, BEO increased [Ca<sup>2+</sup>]<sub>i</sub>
, which was partially inhibited by a nonselective Ca<sup>2+</sup> channel blocker La<sup>3+</sup>. In Ca<sup>2+</sup>-free extracellular solutions, BEO increased [Ca<sup>2+</sup>]<sub>i</sub>
in a concentration-dependent manner, suggesting that BEO mobilizes intracellular Ca<sup>2+</sup>. BEO-induced [Ca<sup>2+</sup>]<sub>i</sub>
increase was partially inhibited by a Ca<sup>2+</sup>-induced Ca<sup>2+</sup> release inhibitor dantrolene, a phospholipase C inhibitor U73122, and an inositol 1,4,5-triphosphate (IP<sub>3</sub>)-gated Ca<sup>2+</sup> channel blocker, 2-aminoethoxydiphenyl borane (2-APB). BEO also increased [Ca<sup>2+</sup>]<sub>i</sub>
in the presence of carbonyl cyanide m-chlorophenylhydrazone, an inhibitor of mitochondrial Ca<sup>2+</sup> uptake. In addition, store-operated Ca<sup>2+</sup> entry (SOC) was potentiated by BEO. These results suggest that BEO mobilizes Ca<sup>2+</sup> from primary intracellular stores via Ca<sup>2+</sup>-induced and IP3-mediated Ca<sup>2+</sup> release and affect promotion of Ca<sup>2+</sup> influx, likely via an SOC mechanism.</p></abstract></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Bergamot essential oil (BEO) is obtained from bergamot (<italic>Citrus bergamia </italic>Risso), a roughly pear-shaped citrus fruit. BEO is widely used in aromatherapy to alleviate symptoms of stress-induced anxiety, mild mood disorders, and cancer pain [<xref rid="B1" ref-type="bibr">1</xref>] and it has anxiolytic [<xref rid="B2" ref-type="bibr">2</xref>] and analgesic [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B4" ref-type="bibr">4</xref>] effects in rodents.</p><p>Besides these effects of BEO, bergamottin, isolated from nonvolatile fraction of BEO, significantly decreased the typical electrocardiographic signs of coronary arterial spasm, the force of the contraction and the incidence of cardiac arrhythmias induced by vasopressin in the guinea pig [<xref rid="B5" ref-type="bibr">5</xref>]. Given the potential roles of bergamottine in cardiovascular function, it is of interest to know the roles of BEO in Ca<sup>2+</sup> mobilization in endothelial cells. Vasorelaxant effect of BEO may involve Ca<sup>2+</sup> mobilization from intracellular stores and/or from the extracellular pool in endothelial cells. Several studies demonstrating the relationship between endothelial cells and smooth muscle relaxation have been reported. Our previous study implicated that a change in cytosolic Ca<sup>2+</sup> levels during stimulation of endothelial cells was a basic mechanism by which endothelial cells modulate vasomotor activity [<xref rid="B6" ref-type="bibr">6</xref>]. Another report indirectly supports this view, demonstrating that the vasorelaxant effect of the essential oil of <italic>Ocimum gratissimum </italic>is partly dependent on the integrity of the vascular endothelium [<xref rid="B7" ref-type="bibr">7</xref>].</p><p>Up till now, the effects of BEO on [Ca<sup>2+</sup>]<sub>i</sub> in endothelial cells and the mechanisms by which BEO modulates the intracellular Ca<sup>2+</sup> concentration ([Ca<sup>2+</sup>]<sub>i</sub>) are not revealed. In the present study, we investigate the intracellular Ca<sup>2+</sup>-regulating properties of BEO in endothelial cells and present evidence that BEO increases [Ca<sup>2+</sup>]<sub>i</sub> via release from intracellular Ca<sup>2+</sup> stores and through store-operated Ca<sup>2+</sup> entry (SOC).</p></sec><sec id="sec2"><title>2. Materials and Methods</title><sec id="sec2.1"><title>2.1. Human Vascular Endothelial Cell Culture</title><p>A human endothelium-derived cell line EA.hy926 was purchased from the American Type Culture Collection (Manassas, VA, USA) [<xref rid="B8" ref-type="bibr">8</xref>]. EA cells were grown in Dulbecco's Modified Eagle Medium (DMEM) containing 20% fetal bovine serum (FBS) and 10% hypoxanthine-aminopterin-thymidine 50 supplement (Life Technologies). Cell cultures were maintained at 37&#x000b0;C in a fully humidified 95% air 5% CO<sub>2</sub> atmosphere. The media were removed and replaced with fresh medium three times in a week. The cells were detached by exposure to trypsin, reseeded on gelatin-coated coverslips, and maintained in culture for 2 to 4 days before use. Measurements were performed on subconfluent cells.</p></sec><sec id="sec2.2"><title>2.2. Cell Viability Assays</title><p>The thiazolyl blue tetrazolium bromide (MTT) assay was used to determine the effects of BEO on cell viability. EA cells were cultured using DMEM with 100% (v/v) FBS (Gibco Invitrogen), 100 units/mL penicillin, 100&#x02009;<italic>&#x003bc;</italic>g/mL streptomycin (Gibco Invitrogen), and MEM nonessential amino acids (Invitrogen) in 96-well plates (Nunclon, Denmark) for 48&#x02009;h until 80&#x02013;90% confluence has been reached. To evaluate the effect of BEO, cells were for 15&#x02009;min with varying concentrations (0.001, 0.005, 0.01, 0.05, or 0.1% [v/v in DMSO]) of the BEO and 0.25% DMSO. Then cells were washed with fresh PBS and replaced with serum-free media. In addition, cells were loaded with 10&#x02009;<italic>&#x003bc;</italic>L MTT (5&#x02009;mg/mL) and incubated at 37&#x000b0;C for 3&#x02009;h. MTT solution was removed and replaced with 100&#x02009;<italic>&#x003bc;</italic>L DMSO in a dark place for 2&#x02009;h. The change in color was read at 540&#x02009;nm using a plate reader.</p></sec><sec id="sec2.3"><title>2.3. Ca<sup>2+</sup> Measurements</title><p>Cells were loaded with fura-2 AM, and [Ca<sup>2+</sup>]<sub>i</sub> was measured using a microfluorometer system consisting of an inverted microscope (IX71, Olympus, Japan) and a PTI Filter Scan power illuminator system (Photon Technology International). Fura-2 AM (2&#x02009;<italic><italic>&#x003bc;</italic></italic>M) was added to the bath and the cells were incubated for 25&#x02009;min at 37&#x000b0;C. The cells were illuminated alternatively at wavelengths of 340 and 380&#x02009;nm through a chopper wheel (frequency = 50&#x02009;Hz). Fluorescence was measured at 510&#x02009;nm, and autofluorescence was subtracted from the signals obtained. The Ca<sup>2+</sup>-free concentration was calculated from the ratio of the fluorescence signals emitted at each excitation wavelength. The calibration procedure was identical to that described previously [<xref rid="B9" ref-type="bibr">9</xref>]. </p></sec><sec id="sec2.4"><title>2.4. Solutions and Chemicals</title><p>The external solution contained the following (in&#x02009;mM): 150 NaCl, 6 KCl, 1.5 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 10 HEPES, and 10 glucose; pH was adjusted to 7.4 with NaOH. Ca<sup>2+</sup>-free solution contained 5&#x02009;mM EGTA in place of Ca<sup>2+</sup>. The osmolarity of this solution, as measured with a vapor pressure osmometer (FISKE, USA), was 320 &#x000b1; 5 mOsm. ATP, 2-aminoethoxydiphenyl borane (2-APB), 2,5-di-t-butyl-1,4-benzohydroquinone (BHQ), carbonyl cyanide m-chlorophenylhydrazone (CCCP), dantrolene, U73122, and MTT were purchased from Sigma; Fura-2 AM was obtained from molecular probes. BHQ, U73122, and essential oil (0.001%, 0.005%, 0.01%, 0.05%, 0.1%, or 0.2% v/v) were applied from a stock solution in dimethyl sulfoxide (DMSO). Final concentration of DMSO was less than 1%. 2-APB was applied from a stock solution in ethanol. The final concentrations of DMSO and ethanol were less than 0.05%. BEO (batch no. 110824) was purchased from Aromarant Co. Ltd., R&#x000f6;ttingen, Germany, and came from locally cultivated plants in Italy. </p></sec><sec id="sec2.5"><title>2.5. Statistical Analysis</title><p>Pooled data are presented as means &#x000b1; SEMs and significant differences were determined using paired <italic>t</italic>-test or ANOVA followed by Scheffe's post-hoc analysis. A value of <italic>P</italic> &#x0003c; .05 was considered significant.</p></sec></sec><sec id="sec3"><title>3. Results</title><sec id="sec3.1"><title>3.1. Cell Viability</title><p>The MTT assay was used to determine explored effect of varying concentrations of BEO in EA cells. Each cell was treated with media (control), DMSO (vehicle, 0.25% [v/v]), or BEO (0.001%, 0.005%, 0.01%, 0.05%, or 0.1% [v/v in DMSO]) for 15&#x02009;min (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Differences between groups were analyzed using the ANOVA followed by Scheffe's post-hoc analysis. There was no significant effect to the percentage of viable cells at all concentrations of BEO in EA cells (<italic>F</italic>(6.27) = 1.541, <italic>P</italic> = .214).</p></sec><sec id="sec3.2"><title>3.2. Elevation of [<italic>Ca</italic>
<sup>2+</sup>]<sub><italic>i</italic></sub> by BEO in Human Vascular Endothelial Cells</title><p>BEO increased [Ca<sup>2+</sup>]<sub>i</sub> in a concentration-dependent manner in EA cells (<xref ref-type="fig" rid="fig2">Figure 2(a)</xref>). The concentration-response relationship for mobilization of Ca<sup>2+</sup> from intracellular stores by BEO is summarized in <xref ref-type="fig" rid="fig2">Figure 2(b)</xref>. The concentration of BEO was nonlinearly related to the increase in [Ca<sup>2+</sup>]<sub>i</sub> as revealed by fitting the Hill equation type dose-response curve. The half maximal increase in [Ca<sup>2+</sup>]<sub>i</sub> (EC<sub>50</sub>) was obtained at 0.04 &#x000b1; 0.01%. DMSO (0.25% v/v) itself did not change intracellular Ca<sup>2+</sup> levels. The cells showed no morphological change after treatment with BEO. Then we investigated whether BEO changed [Ca<sup>2+</sup>]<sub>i</sub> in the presence of extracellular Ca<sup>2+</sup> in EA cells. Application of BEO increased [Ca<sup>2+</sup>]<sub>i</sub> to 1.41 &#x000b1; 0.14&#x02009;<italic>&#x003bc;</italic>M, which was partially and reversibly inhibited by the non-selective Ca<sup>2+</sup> channel blocker La<sup>3+</sup> (1&#x02009;<italic>&#x003bc;</italic>M). [Ca<sup>2+</sup>]<sub>i</sub> was reduced to 1.03 &#x000b1; 0.09&#x02009;<italic>&#x003bc;</italic>M by La<sup>3+</sup> (<italic>P</italic> = .019, <italic>n</italic> = 13, Figures <xref ref-type="fig" rid="fig2">2(c)</xref> and <xref ref-type="fig" rid="fig2">2(d)</xref>), indicating that BEO induces Ca<sup>2+</sup> influx from extracellular pool and Ca<sup>2+</sup> release from intracellular stores. </p></sec><sec id="sec3.3"><title>3.3. Ca<sup>2+</sup> Release from Endoplasmic Reticulum and Mitochondrial Ca<sup>2+</sup> Stores by BEO</title><p>We next performed experiments to determine which of the two main dynamic intracellular Ca<sup>2+</sup> stores, namely, the endoplasmic reticulum (ER) and mitochondria, is affected by BEO in EA cells. Ca<sup>2+</sup> release from the ER depends on two mechanisms: Ca<sup>2+</sup>-induced Ca<sup>2+</sup> release (CICR), involving ryanodine receptors, and IP<sub>3</sub>-induced Ca<sup>2+</sup> release (IICR), involving inositol 1,4,5-triphosphate (IP<sub>3</sub>) receptors [<xref rid="B10" ref-type="bibr">10</xref>]. BEO-induced intracellular Ca<sup>2+</sup> increase was significantly and reversibly inhibited by the CICR inhibitor, dantrolene (<italic>P</italic> &#x0003c; .001, <italic>n</italic> = 10, <xref ref-type="fig" rid="fig3">Figure 3(a)</xref>). These data indicate that BEO elevates [Ca<sup>2+</sup>]<sub>i</sub> in part by the release of Ca<sup>2+</sup> from intracellular stores via a CICR mechanism. To determine whether BEO releases Ca<sup>2+</sup> from intracellular Ca<sup>2+</sup> stores via IICR, we tested the effects of BEO in the presence of U73122, the specific inhibitor of phospholipase C (PLC) [<xref rid="B11" ref-type="bibr">11</xref>], to inhibit IP<sub>3</sub> synthesis, or 2-APB, a membrane-permeable inhibitor of IP<sub>3</sub>-gated ER Ca<sup>2+</sup> channels [<xref rid="B12" ref-type="bibr">12</xref>]. BEO-induced intracellular Ca<sup>2+</sup> increase was significantly inhibited by both U73122 (<italic>P</italic> &#x0003c; .001, <italic>n</italic> = 10, <xref ref-type="fig" rid="fig3">Figure 3(b)</xref>) and 2-APB (<italic>P</italic> &#x0003c; .001, <italic>n</italic> = 15, <xref ref-type="fig" rid="fig3">Figure 3(c)</xref>). These data indicate that PLC-mediated synthesis of IP<sub>3</sub> and IP<sub>3</sub> binding to IP<sub>3</sub>-gated Ca<sup>2+</sup> channels in the ER contribute to BEO-induced Ca<sup>2+</sup> release from intracellular stores.</p><p>A portion of Ca<sup>2+</sup> released from the ER is taken up by proximate mitochondria, which can also release Ca<sup>2+</sup> and thereby regulate [Ca<sup>2+</sup>]<sub>i</sub>. To determine whether mitochondria participate in the reuptake of BEO-induced Ca<sup>2+</sup> release, we examined the effects of BEO on [Ca<sup>2+</sup>]<sub>i</sub> in a Ca<sup>2+</sup>-free solution in the presence of BHQ (an SR/ER Ca<sup>2+</sup>-ATPase inhibitor) and CCCP (a mitochondrial Ca<sup>2+</sup> uptake inhibitor). In cells treated with BHQ and/or CCCP, [Ca<sup>2+</sup>]<sub>i</sub> transiently increased and then decreased slowly to a steady state, suggesting that an SR/ER Ca<sup>2+</sup>-ATPase and mitochondrial Ca<sup>2+</sup> uptake participate in the regulation of [Ca<sup>2+</sup>]<sub>i</sub> under basal conditions (<xref ref-type="fig" rid="fig4">Figure 4(a)</xref>). Increase in [Ca<sup>2+</sup>]<sub>i</sub> in EA cells by subsequent application of BEO in the presence of BHQ and CCCP was higher than that in the presence of BHQ only. An area under the curve in each condition was 72.97 &#x000b1; 8.81 and 31.62 &#x000b1; 2.75 arbitrary unit, respectively. The difference between two conditions was 41.35 &#x000b1; 8.12 arbitrary unit, suggesting that mitochondrial Ca<sup>2+</sup> stores may contribute to the regulation of the BEO-induced increase in [Ca<sup>2+</sup>]<sub>i</sub>. </p><p>Considering the inhibitory effect of La<sup>3+</sup>, noted above, it is suggested that Ca<sup>2+</sup>-entry pathway(s) is (are) activated by BEO. Thus, we next examined whether BEO modulated Ca<sup>2+</sup> entry via an SOC mechanism. Exposure of EA cells to the BHQ in a Ca<sup>2+</sup>-free solution induced a transient increase in [Ca<sup>2+</sup>]<sub>i</sub>, which then decreased slowly to a steady state (<xref ref-type="fig" rid="fig4">Figure 4(a)</xref>). Reapplication of extracellular Ca<sup>2+</sup> following emptying of intracellular Ca<sup>2+</sup> stores with BHQ caused an increase in [Ca<sup>2+</sup>]<sub>i</sub>, indicating activation of an SOC mechanism. When BEO was applied after SOC was evoked, SOC was further enhanced, suggesting that BEO also activates Ca<sup>2+</sup> influx through an SOC pathway (<xref ref-type="fig" rid="fig4">Figure 4(b)</xref>). However, using this protocol alone in this experiment does not rule out that other calcium entry pathways may be activated by BEO.</p></sec></sec><sec id="sec4"><title>4. Discussion </title><p>In the present study, we firstly demonstrate that BEO mobilized Ca<sup>2+</sup> from extracellular and intracellular sources in endothelial cells. Our present results also suggest that BEO increased intracellular Ca<sup>2+</sup> level through both mobilization of intracellular Ca<sup>2+</sup> stores, ER and mitochondria, and promotion of Ca<sup>2+</sup> influx, via an SOC mechanism. These findings will provide insight into the physiological mechanisms involved in Ca<sup>2+</sup> regulation in endothelial cells following exposure to BEO.</p><p>Some essential oils contain photoactive molecules like furocoumarins. For instance, essential oil of <italic>Citrus bergamia</italic> contains psoralens which bind to DNA under ultraviolet A light exposure producing mono- and biadducts that are cytotoxic and highly mutagenic [<xref rid="B13" ref-type="bibr">13</xref>]. Therefore, the results observed in the present study may be results from the effects of photoirritation of BEO. Since, however, intracellular Ca<sup>2+</sup> level rapidly returned to a baseline level after washing out of BEO and cell viability was normal in doses tested, we think that phototoxic or cytotoxic effect is little on intracellular Ca<sup>2+</sup> level by BEO. In addition, <italic>in vitro</italic> studies have shown that BEO reduces glutamate receptor-mediated cell death induced by N-methyl-D-aspartate [<xref rid="B14" ref-type="bibr">14</xref>]. Nevertheless, further researches are necessary to evaluate phototoxic potential of BEO in endothelial cells.</p><p>BEO has been reported to decrease the blood pressure in healthy human and have dilating effect on mouse artery [<xref rid="B15" ref-type="bibr">15</xref>, <xref rid="B16" ref-type="bibr">16</xref>]. In the recent study, limonene, one of the major components of BEO (37.26%), increased cytosolic Ca<sup>2+</sup> concentration by the direct activation of adenosine A<sub>2A</sub> receptors [<xref rid="B17" ref-type="bibr">17</xref>]. In endothelium, an adenosine A<sub>2A</sub> receptor has an important role in NO release. Adenosine A<sub>2A</sub> receptor induced NO-dependent vasodilation by intracellular Ca<sup>2+</sup> increase [<xref rid="B18" ref-type="bibr">18</xref>]. Thus, we suggest that the effect of BEO may be attributable to limonene by activation of adenosine A<sub>2A</sub> receptors.</p><p>Contraction and relaxation of smooth muscle are regulated not only by changes in cytoplasmic calcium concentration but also by other important signaling mechanisms, that is, independent of the changes in [Ca<sup>2+</sup>]<sub>i</sub>, known as Ca<sup>2+</sup> sensitization [<xref rid="B19" ref-type="bibr">19</xref>]. Although the increase in [Ca<sup>2+</sup>]<sub>i</sub> initiates smooth muscle contraction via activating myosin light chain kinase, Ca<sup>2+</sup> sensitization mediates smooth muscle contraction by modulating myosin light chain phosphatase [<xref rid="B20" ref-type="bibr">20</xref>]. The increase in [Ca<sup>2+</sup>]<sub>i</sub> in endothelial cell plays a role in synthesis and the release of vasoactive compounds such as nitric oxide or prostaglandins [<xref rid="B21" ref-type="bibr">21</xref>], thereby altering Ca<sup>2+</sup> sensitization in smooth muscle cells. It has been reported that linalyl acetate, one of the main components of BEO, induces relaxation of the smooth muscle via partially endothelium-dependent pathway [<xref rid="B22" ref-type="bibr">22</xref>]. Further research will be needed to reveal the mechanism by which the calcium releasing actions by BEO in endothelial cells regulate to the vasodilator action.</p><p>In conclusion, before BEO can be considered for use in treating vascular-related diseases, further studies are necessary to define the Ca<sup>2+</sup>-elevating pathways enlisted by BEO under pathological conditions.</p></sec></body><back><ack><title>Conflict of Interests</title><p>The authors declare they have no conflict of interests.</p></ack><ack><title>Authors' Contribution</title><p>Purum Kang, Seung Ho Han, and Hea Kyung Moon contributed equally to this work.</p></ack><ack><title>Acknowledgment</title><p>This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MEST) (2012-0004065, 2012-007145). </p></ack><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bagetta</surname><given-names>G</given-names></name><name><surname>Morrone</surname><given-names>LA</given-names></name><name><surname>Rombol&#x000e0;</surname><given-names>L</given-names></name><etal/></person-group><article-title>Neuropharmacology of the essential oil of bergamot</article-title><source><italic>Fitoterapia</italic></source><year>2010</year><volume>81</volume><issue>6</issue><fpage>453</fpage><lpage>461</lpage><pub-id pub-id-type="other">2-s2.0-77955711210</pub-id><pub-id pub-id-type="pmid">20093169</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saiyudthong</surname><given-names>S</given-names></name><name><surname>Marsden</surname><given-names>CA</given-names></name></person-group><article-title>Acute effects of bergamot oil on anxiety-related behaviour and corticosterone level in rats</article-title><source><italic>Phytotherapy Research</italic></source><year>2011</year><volume>25</volume><issue>6</issue><fpage>858</fpage><lpage>862</lpage><pub-id pub-id-type="other">2-s2.0-79957809174</pub-id><pub-id pub-id-type="pmid">21105176</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakurada</surname><given-names>T</given-names></name><name><surname>Kuwahata</surname><given-names>H</given-names></name><name><surname>Katsuyama</surname><given-names>S</given-names></name><etal/></person-group><article-title>Intraplantar injection of bergamot essential oil into the mouse hindpaw: effects on capsaicin-induced nociceptive behaviors</article-title><source><italic>International Review of Neurobiology</italic></source><year>2009</year><volume>85</volume><fpage>237</fpage><lpage>248</lpage><pub-id pub-id-type="other">2-s2.0-67650070882</pub-id><pub-id pub-id-type="pmid">19607974</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakurada</surname><given-names>T</given-names></name><name><surname>Mizoguchi</surname><given-names>H</given-names></name><name><surname>Kuwahata</surname><given-names>H</given-names></name><etal/></person-group><article-title>Intraplantar injection of bergamot essential oil induces peripheral antinociception mediated by opioid mechanism</article-title><source><italic>Pharmacology Biochemistry and Behavior</italic></source><year>2011</year><volume>97</volume><issue>3</issue><fpage>436</fpage><lpage>443</lpage><pub-id pub-id-type="other">2-s2.0-78049522454</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Occhiuto</surname><given-names>F</given-names></name><name><surname>Circosta</surname><given-names>C</given-names></name></person-group><article-title>Cardiovascular properties of the non-volatile total residue from the essential oil or <italic>Citrus bergamia</italic>
</article-title><source><italic>International Journal of Pharmacognosy</italic></source><year>1996</year><volume>34</volume><issue>2</issue><fpage>128</fpage><lpage>133</lpage><pub-id pub-id-type="other">2-s2.0-0029896523</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seol</surname><given-names>GH</given-names></name><name><surname>Ahn</surname><given-names>SC</given-names></name><name><surname>Kim</surname><given-names>JA</given-names></name><name><surname>Nilius</surname><given-names>B</given-names></name><name><surname>Suh</surname><given-names>SH</given-names></name></person-group><article-title>Inhibition of endothelium-dependent vasorelaxation by extracellular K<sup>+</sup>: a novel controlling signal for vascular contractility</article-title><source><italic>American Journal of Physiology&#x02014;Heart and Circulatory Physiology</italic></source><year>2004</year><volume>286</volume><issue>1</issue><fpage>H329</fpage><lpage>H339</lpage><pub-id pub-id-type="other">2-s2.0-0346368251</pub-id><pub-id pub-id-type="pmid">12969893</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Interaminense</surname><given-names>LFL</given-names></name><name><surname>Juc&#x000e1;</surname><given-names>DM</given-names></name><name><surname>Magalh&#x000e3;es</surname><given-names>PJC</given-names></name><name><surname>Leal-Cardoso</surname><given-names>JH</given-names></name><name><surname>Duarte</surname><given-names>GP</given-names></name><name><surname>Lahlou</surname><given-names>S</given-names></name></person-group><article-title>Pharmacological evidence of calcium-channel blockade by essential oil of Ocimum gratissimum and its main constituent, eugenol, in isolated aortic rings from DOCA-salt hypertensive rats</article-title><source><italic>Fundamental and Clinical Pharmacology</italic></source><year>2007</year><volume>21</volume><issue>5</issue><fpage>497</fpage><lpage>506</lpage><pub-id pub-id-type="other">2-s2.0-34548638854</pub-id><pub-id pub-id-type="pmid">17868202</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Edgell</surname><given-names>CJS</given-names></name><name><surname>McDonald</surname><given-names>CC</given-names></name><name><surname>Graham</surname><given-names>JB</given-names></name></person-group><article-title>Permanent cell line expressing human factor VIII-related antigen established by hybridization</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>1983</year><volume>80</volume><issue>12</issue><fpage>3734</fpage><lpage>3737</lpage><pub-id pub-id-type="other">2-s2.0-0001637870</pub-id><pub-id pub-id-type="pmid">6407019</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nilius</surname><given-names>B</given-names></name><name><surname>Schwartz</surname><given-names>G</given-names></name><name><surname>Oike</surname><given-names>M</given-names></name><name><surname>Droogmans</surname><given-names>G</given-names></name></person-group><article-title>Histamine-activated, non-selective cation currents and Ca<sup>2+</sup> transients in endothelial cells from human umbilical vein</article-title><source><italic>Pflugers Archiv&#x02014;European Journal of Physiology</italic></source><year>1993</year><volume>424</volume><issue>3-4</issue><fpage>285</fpage><lpage>293</lpage><pub-id pub-id-type="other">2-s2.0-0027218675</pub-id><pub-id pub-id-type="pmid">7692391</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iino</surname><given-names>M</given-names></name></person-group><article-title>Calcium-induced calcium release mechanism in guinea pig taenia caeci</article-title><source><italic>Journal of General Physiology</italic></source><year>1989</year><volume>94</volume><issue>2</issue><fpage>363</fpage><lpage>383</lpage><pub-id pub-id-type="other">2-s2.0-0024427220</pub-id><pub-id pub-id-type="pmid">2794970</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gabev</surname><given-names>E</given-names></name><name><surname>Kasianowicz</surname><given-names>J</given-names></name><name><surname>Abbott</surname><given-names>T</given-names></name><name><surname>McLaughlin</surname><given-names>S</given-names></name></person-group><article-title>Binding of neomycin to phosphatidylinositol 4,5-bisphosphate (PIP2)</article-title><source><italic>Biochimica et Biophysica Acta</italic></source><year>1989</year><volume>979</volume><issue>1</issue><fpage>105</fpage><lpage>112</lpage><pub-id pub-id-type="other">2-s2.0-0024576602</pub-id><pub-id pub-id-type="pmid">2537103</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruyama</surname><given-names>T</given-names></name><name><surname>Kanaji</surname><given-names>T</given-names></name><name><surname>Nakade</surname><given-names>S</given-names></name><name><surname>Kanno</surname><given-names>T</given-names></name><name><surname>Mikoshiba</surname><given-names>K</given-names></name></person-group><article-title>2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(l,4,5)P3-induced Ca<sup>2+</sup> release</article-title><source><italic>Journal of Biochemistry</italic></source><year>1997</year><volume>122</volume><issue>3</issue><fpage>498</fpage><lpage>505</lpage><pub-id pub-id-type="other">2-s2.0-0030843234</pub-id><pub-id pub-id-type="pmid">9348075</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bakkali</surname><given-names>F</given-names></name><name><surname>Averbeck</surname><given-names>S</given-names></name><name><surname>Averbeck</surname><given-names>D</given-names></name><name><surname>Idaomar</surname><given-names>M</given-names></name></person-group><article-title>Biological effects of essential oils&#x02014;a review</article-title><source><italic>Food and Chemical Toxicology</italic></source><year>2008</year><volume>46</volume><issue>2</issue><fpage>446</fpage><lpage>475</lpage><pub-id pub-id-type="other">2-s2.0-37349104213</pub-id><pub-id pub-id-type="pmid">17996351</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Corasaniti</surname><given-names>MT</given-names></name><name><surname>Maiuolo</surname><given-names>J</given-names></name><name><surname>Maida</surname><given-names>S</given-names></name><etal/></person-group><article-title>Cell signaling pathways in the mechanisms of neuroprotection afforded by bergamot essential oil against NMDA-induced cell death in vitro</article-title><source><italic>British Journal of Pharmacology</italic></source><year>2007</year><volume>151</volume><issue>4</issue><fpage>518</fpage><lpage>529</lpage><pub-id pub-id-type="other">2-s2.0-34250191484</pub-id><pub-id pub-id-type="pmid">17401440</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>K-M</given-names></name><name><surname>Shen</surname><given-names>C-W</given-names></name></person-group><article-title>Aromatherapy benefits autonomic nervous system regulation for elementary school faculty in Taiwan</article-title><source><italic>Evidence-Based Complementary and Alternative Medicine</italic></source><year>2011</year><volume>2011</volume><fpage>7 pages</fpage><pub-id pub-id-type="other">2-s2.0-79959241168</pub-id><pub-id pub-id-type="publisher-id">946537</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>P</given-names></name><name><surname>Suh</surname><given-names>SH</given-names></name><name><surname>Min</surname><given-names>SS</given-names></name><name><surname>Seol</surname><given-names>GH</given-names></name></person-group><article-title>The essential oil of <italic>Citrus bergamia</italic>Risso induces vasorelaxation of the mouse aorta by activating K<sup>+</sup> channels and inhibiting Ca<sup>2+</sup> influx</article-title><source><italic>Journal of Pharmacy and Pharmacology</italic></source><year>2013</year><volume>65</volume><issue>5</issue><fpage>745</fpage><lpage>749</lpage><pub-id pub-id-type="pmid">23600392</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>HM</given-names></name><name><surname>Lee</surname><given-names>JH</given-names></name><name><surname>Yaoyao</surname><given-names>J</given-names></name><name><surname>Jun</surname><given-names>HJ</given-names></name><name><surname>Lee</surname><given-names>SJ</given-names></name></person-group><article-title>Limonene, a natural cyclic terpene, is an agonistic ligand for adenosine A<sub>2A</sub> receptors</article-title><source><italic>Biochemical and Biophysical Research Communications</italic></source><year>2011</year><volume>404</volume><issue>1</issue><fpage>345</fpage><lpage>348</lpage><pub-id pub-id-type="other">2-s2.0-78650861063</pub-id><pub-id pub-id-type="pmid">21134357</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ray</surname><given-names>CJ</given-names></name><name><surname>Marshall</surname><given-names>JM</given-names></name></person-group><article-title>The cellular mechanisms by which adenosine evokes release of nitric oxide from rat aortic endothelium</article-title><source><italic>Journal of Physiology</italic></source><year>2006</year><volume>570, part 1</volume><fpage>85</fpage><lpage>96</lpage><pub-id pub-id-type="other">2-s2.0-33645990346</pub-id><pub-id pub-id-type="pmid">16239264</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hori</surname><given-names>M</given-names></name><name><surname>Karaki</surname><given-names>H</given-names></name></person-group><article-title>Regulatory mechanisms of calcium sensitization of contractile elements in smooth muscle</article-title><source><italic>Life Sciences</italic></source><year>1998</year><volume>62</volume><issue>17-18</issue><fpage>1629</fpage><lpage>1633</lpage><pub-id pub-id-type="other">2-s2.0-0032571235</pub-id><pub-id pub-id-type="pmid">9585148</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somlyo</surname><given-names>AP</given-names></name><name><surname>Somlyo</surname><given-names>AV</given-names></name></person-group><article-title>Ca<sup>2+</sup> sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase</article-title><source><italic>Physiological Reviews</italic></source><year>2003</year><volume>83</volume><issue>4</issue><fpage>1325</fpage><lpage>1358</lpage><pub-id pub-id-type="other">2-s2.0-0141751697</pub-id><pub-id pub-id-type="pmid">14506307</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lantoine</surname><given-names>F</given-names></name><name><surname>Iouzalen</surname><given-names>L</given-names></name><name><surname>Devynck</surname><given-names>M-A</given-names></name><name><surname>Millanvoye-Van Brussel</surname><given-names>E</given-names></name><name><surname>David-Dufilho</surname><given-names>M</given-names></name></person-group><article-title>Nitric oxide production in human endothelial cells stimulated by histamine requires Ca<sup>2+</sup> influx</article-title><source><italic>Biochemical Journal</italic></source><year>1998</year><volume>330</volume><issue>2</issue><fpage>695</fpage><lpage>699</lpage><pub-id pub-id-type="other">2-s2.0-0032032368</pub-id><pub-id pub-id-type="pmid">9480877</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koto</surname><given-names>R</given-names></name><name><surname>Imamura</surname><given-names>M</given-names></name><name><surname>Watanabe</surname><given-names>C</given-names></name><etal/></person-group><article-title>Linalyl acetate as a major ingredient of lavender essential oil relaxes the rabbit vascular smooth muscle through dephosphorylation of myosin light chain</article-title><source><italic>Journal of Cardiovascular Pharmacology</italic></source><year>2006</year><volume>48</volume><issue>1</issue><fpage>850</fpage><lpage>856</lpage><pub-id pub-id-type="other">2-s2.0-33747777068</pub-id><pub-id pub-id-type="pmid">16891914</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>The cell survival percentage measured using MTT assay after 15&#x02009;min posttreatment of bergamot essential oil, one-way ANOVA followed by Scheffe's post hoc test (<italic>n</italic> = 4).</p></caption><graphic xlink:href="ECAM2013-759615.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Application of BEO increased [Ca<sup>2+</sup>]<sub>i</sub> in a concentration-dependent manner (a). Summary data describing the concentration-response relationship for BEO effects on [Ca<sup>2+</sup>]<sub>i</sub> (b). Data are means &#x000b1; SEMs. Applications of BEO or drugs are indicated by upper or bottom lines. Effects of BEO on [Ca<sup>2+</sup>]<sub>i</sub> in human vascular endothelial cells. In the presence of extracellular Ca<sup>2+</sup>, application of BEO (0.1% v/v) induced an increase in [Ca<sup>2+</sup>]<sub>i</sub> that was significantly inhibited by La<sup>3+</sup> (1&#x02009;<italic><italic>&#x003bc;</italic></italic>M) ((c), (d)). *<italic>P</italic> &#x0003c; .05 compared to the BEO group; <italic>n</italic> = 10~13 cells/group.</p></caption><graphic xlink:href="ECAM2013-759615.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Involvement of CICR and IICR on BEO-induced intracellular Ca<sup>2+</sup> release. Effects of CICR inhibitor, dantrolene (10&#x02009;<italic><italic>&#x003bc;</italic></italic>M) on BEO-induced intracellular Ca<sup>2+</sup> release. Application of dantrolene partially attenuated increase in [Ca<sup>2+</sup>]<sub>i</sub> by BEO (the first upper line) (a). Involvement of IICR pathways in BEO-induced intracellular Ca<sup>2+</sup> release ((b), (c)). Increased [Ca<sup>2+</sup>]<sub>i</sub> by BEO was significantly inhibited by inhibitors of PLC (U73122, 10&#x02009;<italic><italic>&#x003bc;</italic></italic>M) or IP<sub>3</sub> receptors (2-APB, 10&#x02009;<italic><italic>&#x003bc;</italic></italic>M). </p></caption><graphic xlink:href="ECAM2013-759615.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Involvement of mitochondrial Ca<sup>2+</sup> uptake and SOC pathway on BEO-induced Ca<sup>2+</sup> release. Inhibition of mitochondrial Ca<sup>2+</sup> uptake and SR/ER Ca<sup>2+</sup>-ATPase on BEO-induced Ca<sup>2+</sup> release with CCCP (20&#x02009;<italic><italic>&#x003bc;</italic></italic>M) and BHQ (30&#x02009;<italic><italic>&#x003bc;</italic></italic>M), respectively (a). Increase in [Ca<sup>2+</sup>]<sub>i</sub> by subsequent application of BEO in the presence of BHQ and CCCP (black trace a) was higher than that in the presence of BHQ only (gray trace b). Effects of SOC pathway in BEO-induced intracellular Ca<sup>2+</sup> release. SOC was induced by reintroduction of extracellular Ca<sup>2+</sup> following SR/ER Ca<sup>2+</sup>-ATPase inhibition with BHQ (b). Intracellular Ca<sup>2+</sup> levels were further enhanced by subsequent addition of BEO. Data are means &#x000b1; SEMs. **<italic>P</italic> &#x0003c; .01; <italic>n</italic> = 15 cells/group. Applications of BEO or drugs are indicated by upper or bottom lines.</p></caption><graphic xlink:href="ECAM2013-759615.004"/></fig></floats-group></article>